Ceapro (CZO) News Today C$0.22 -0.03 (-11.76%) (As of 05/31/2024) Add Compare Share Share Headlines Stock AnalysisEarnings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Ceapro (CVE:CZO) Stock Price Down 11.8% - Time to Sell?December 19 at 2:05 AM | americanbankingnews.comUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyMarch 12, 2024 | nz.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyDecember 14, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 29, 2023 | finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | nz.finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesNovember 27, 2023 | finance.yahoo.comClosing Bell: Ceapro Inc flat on Wednesday (CZO)September 14, 2023 | theglobeandmail.comCeapro Inc. (CZO.V)September 6, 2023 | ca.finance.yahoo.comClosing Bell: Ceapro Inc up on Wednesday (CZO)August 3, 2023 | theglobeandmail.comAre Ceapro Inc.'s (CVE:CZO) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?July 30, 2023 | finance.yahoo.comClosing Bell: Ceapro Inc down on Wednesday (CZO)July 19, 2023 | theglobeandmail.comCeapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate UpdateMay 25, 2023 | stockhouse.comClosing Bell: Ceapro Inc up on Friday (CZO)May 13, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Tuesday (CZO)May 3, 2023 | theglobeandmail.comCeapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue RegenerationMay 3, 2023 | finance.yahoo.comClosing Bell: Ceapro Inc down on Friday (CZO)April 22, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Thursday (CZO)April 21, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Tuesday (CZO)April 19, 2023 | theglobeandmail.comCeapro Inc. Reports Record 2022 Financial Results and Operational HighlightsApril 12, 2023 | finance.yahoo.comClosing Bell: Ceapro Inc down on Monday (CZO)April 11, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc flat on Thursday (CZO)April 6, 2023 | theglobeandmail.comIs Weakness In Ceapro Inc. (CVE:CZO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?February 20, 2023 | finance.yahoo.comReturns At Ceapro (CVE:CZO) Are On The Way UpNovember 11, 2022 | uk.finance.yahoo.comCeapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed CarriersOctober 13, 2022 | finance.yahoo.comCeapro: A Moat In OatOctober 12, 2022 | seekingalpha.comIs Ceapro Inc.'s (CVE:CZO) Latest Stock Performance A Reflection Of Its Financial Health?September 12, 2022 | nz.finance.yahoo.comCeapro Inc. Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate UpdateAugust 24, 2022 | finance.yahoo.comCZO.V - Ceapro Inc | Stock Price & Latest News | ReutersAugust 16, 2022 | reuters.comCeapro (CVE:CZO) Has More To Do To Multiply In Value Going ForwardJune 4, 2022 | finance.yahoo.comCeapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate UpdateMay 18, 2022 | stockhouse.comCeapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 UtilizationMay 11, 2022 | nz.finance.yahoo.comA Look At The Intrinsic Value Of Ceapro Inc. (CVE:CZO)May 3, 2022 | finance.yahoo.comCeapro Inc. Announces Appointment of Geneviève Foster to Board of DirectorsApril 19, 2022 | stockhouse.comCeapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical IndustryMarch 2, 2022 | finance.yahoo.comCeapro's (CVE:CZO) Returns On Capital Not Reflecting Well On The BusinessDecember 26, 2021 | news.yahoo.comCeapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 8, 2021 | stockhouse.comCeapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study ...August 12, 2021 | apnews.comCeapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, AvenanthramideAugust 11, 2021 | finance.yahoo.comGetting In Cheap On Ceapro Inc. (CVE:CZO) Is UnlikelyJuly 28, 2021 | finance.yahoo.com Get Ceapro News Delivered to You Automatically Sign up to receive the latest news and ratings for CZO and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… CZO Media Mentions By Week CZO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CZO News Sentiment▼0.000.60▲Average Medical News Sentiment CZO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CZO Articles This Week▼10▲CZO Articles Average Week Get Ceapro News Delivered to You Automatically Sign up to receive the latest news and ratings for CZO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Microbix Biosystems News Aeterna Zentaris News Resverlogix News Sirona Biochem News Kane Biotech News Innovotech News Hemostemix News Quest PharmaTech News Aptose Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:CZO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ceapro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
